Incyte (Nasdaq:INCY) announced today that it will present at the Bank of America Securities 2024 Health Care Conference on Wednesday, May 15, 2024 at 8:00 a.m. (PDT) in Las Vegas.
The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.
About Incyte
A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.
Kamux Corporation's Interim Report for January 1?March 31, 2024: Revenue grew and adjusted operating profit increased significantly, actions in Sweden are progressing
This is a summary of Kamux Corporation's Interim Report for January 1?March 31,...
FPT Software, a leading global technology company, has been listed in the Gartner Market Guide for Public Cloud Managed & Professional Services in the Asia Pacific region for the year 2024. This marks the third consecutive time that FPT Software has...
QuTEM AB (formerly Vironova BioAnalytics AB), a leading provider of transmission electron microscopy (TEM) services, proudly announces the receipt of GMP (Good Manufacturing Practice) Certificates and Manufacturing Permits for Independent Quality...
The global hospitality robots market size is estimated to grow by USD 471.77 mn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 14.19% during the forecast period. ...
Brinc, a global leader in corporate innovation and venture acceleration has acquired Callmi, a MENA-centric mentorship platform that offers 1:1 video consultations with top-tier expertsCallmi will scale offerings to users and also be further...